Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Leuk Res. 2015 Apr 22;39(7):757–762. doi: 10.1016/j.leukres.2015.04.008

Table 3.

Percent inhibition at 3 IU/ml ASNase

Cell line dm HpA wt HpA L-ASP ERWase
SupB15 92 92 93 92
RS4;11 91 91 90 85
MOLT-4 84 94* 95* 95*
SEM 27 47** 58** 78**
BV173 6 32** 35** 66**
HL-60 12 33 31 62**
SD-1 0 15 34 67**
REH 0 35** 47** 62**
RCH-ACV 0 29** 20** 51**
NALM6 4 18 18 51**
K-562 0 0 0 32**

The percentage of inhibition at 3 IU/ml was calculated from normalized data (Fig 2). Each ASNase isoforms was compared to untreated cells control using 2 way ANOVA with Bonferroni post-tests.

*

p<.05,

**

p<.01 vs. dm HpA; n = 4–5 for each cell line.